Company Filing History:
Years Active: 1998-1999
Title: Innovations by Yephet Gamlieli in Blood Filtration Technology
Introduction
Yephet Gamlieli is an accomplished inventor based in Rishon Lezion, Israel. He has made significant contributions to the field of medical technology, particularly in blood filtration systems. With a total of two patents to his name, Gamlieli's work focuses on improving the efficiency and effectiveness of leukocyte removal from blood products.
Latest Patents
Gamlieli's latest patents include a "Whole blood and platelet leukocyte filtration apparatus" and a "Whole blood and platelet leukocyte filtration method." Both inventions describe a method for selectively removing leukocytes from a suspension that contains platelets, such as platelet concentrates or whole blood. The innovative method involves passing the suspension through a filter that features a polysaccharide-type coating. This coating may consist of various substances, including hydroxypropylmethyl cellulose, hydroxybutylmethyl cellulose, dextran, and hydroxyethyl starch. Additionally, the filter is designed to effectively remove leukocytes while preserving the integrity of the platelets.
Career Highlights
Gamlieli is currently associated with Teva Medical Ltd., a company known for its advancements in medical technologies. His work at Teva Medical Ltd. has allowed him to focus on developing solutions that enhance patient care through innovative filtration techniques.
Collaborations
Throughout his career, Gamlieli has collaborated with notable professionals in the field, including Menahem A Kraus and Jacob Yonath. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Yephet Gamlieli's contributions to blood filtration technology demonstrate his commitment to improving medical practices. His innovative patents reflect a deep understanding of the complexities involved in blood product processing. Gamlieli's work continues to have a positive impact on the medical field, enhancing the safety and efficacy of blood transfusions.